58.00
-1.34
(-2.26%)
As of April 8 at 7:13:07 PM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 9 | 18 | 19 |
| Avg. Estimate | 4.61B | 4.66B | 19.52B | 19.32B |
| Low Estimate | 4.56B | 4.43B | 19.24B | 18.31B |
| High Estimate | 4.69B | 4.89B | 19.62B | 20.6B |
| Year Ago Sales | 4.71B | 4.85B | 19.86B | 19.52B |
| Sales Growth (year/est) | -2.13% | -3.95% | -1.69% | -1.05% |
EPS Trend
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0R1X.L | -- | -- | -- | -- |
| S&P 500 | 6.55% | 6.50% | 9.70% | 14.29% |
Upgrades & Downgrades
| Initiated | Morgan Stanley: Underweight | 3/24/2025 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 3/21/2025 |
| Maintains | Mizuho: Neutral to Neutral | 3/20/2025 |
| Maintains | JP Morgan: Neutral to Neutral | 3/20/2025 |
| Maintains | B of A Securities: Buy to Buy | 3/20/2025 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 3/18/2025 |